{"entity":"novo-nordisk","id":"ent_novo-nordisk","name":"Novo Nordisk","from":"2025-11-10","to":"2026-11-10","page":"https://asof.is/record/novo-nordisk/diff?from=2025-11-10&to=2026-11-10","summary":"Between 2025-11-10 and 2026-11-10, Novo Nordisk's record changed in 6 facts: 6 replaced (employees 77,349 employee → 69,505 employee; net income 100.99 billion DKK → 102.43 billion DKK; operating income 128.34 billion DKK → 127.66 billion DKK and 3 more); 13 unchanged.","counts":{"changed":6,"added":0,"ended":0,"replaced":6,"unchanged":13,"skipped_posts":{"from":0,"to":0}},"by_predicate":[{"predicate":"employees","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"net_income","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"operating_income","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"revenue","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"total_assets","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"total_equity","added":0,"ended":0,"replaced":1,"unchanged":0},{"predicate":"ceo","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"chair","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"cik","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"fiscal_year_end","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"headquarters","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"listed_on","added":0,"ended":0,"replaced":0,"unchanged":2},{"predicate":"registrant_name","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"sic_industry","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"ticker","added":0,"ended":0,"replaced":0,"unchanged":2},{"predicate":"website","added":0,"ended":0,"replaced":0,"unchanged":1},{"predicate":"x_username","added":0,"ended":0,"replaced":0,"unchanged":1}],"added":[],"ended":[],"replaced":[{"predicate":"employees","from":{"id":"clm_6A7CC2B7840B","predicate":"employees","value":"77,349 employee","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novo Nordisk employees: 77,349 employee\", as of 2024-12-31 (until 2025-12-31). Claim clm_6A7CC2B7840B, https://asof.is/claim/clm_6A7CC2B7840B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm.","url":"https://asof.is/claim/clm_6A7CC2B7840B","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8EB909BEF688","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-02-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityNumberOfEmployees in 20-F FY2024, filed 2025-02-05"}},"to":{"id":"clm_8EB909BEF688","predicate":"employees","value":"69,505 employee","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novo Nordisk employees: 69,505 employee\", as of 2025-12-31. Claim clm_8EB909BEF688, https://asof.is/claim/clm_8EB909BEF688, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm.","url":"https://asof.is/claim/clm_8EB909BEF688","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q818846","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"},{"url":"https://ml-eu.globenewswire.com/Resource/Download/7c7c1d6f-42c0-4e8f-821c-93ff9a0858c0","tier":"secondary","publisher":null,"published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityNumberOfEmployees in 20-F FY2025, filed 2026-02-04"}}},{"predicate":"net_income","from":{"id":"clm_8A5C5EE097FD","predicate":"net_income","value":"100,988,000,000 DKK","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novo Nordisk net income: 100,988,000,000 DKK\", as of 2024-12-31 (until 2025-12-31). Claim clm_8A5C5EE097FD, https://asof.is/claim/clm_8A5C5EE097FD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm.","url":"https://asof.is/claim/clm_8A5C5EE097FD","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F536BDE429B7","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-02-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2024, filed 2025-02-05"}},"to":{"id":"clm_F536BDE429B7","predicate":"net_income","value":"102,434,000,000 DKK","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novo Nordisk net income: 102,434,000,000 DKK\", as of 2025-12-31. Claim clm_F536BDE429B7, https://asof.is/claim/clm_F536BDE429B7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm.","url":"https://asof.is/claim/clm_F536BDE429B7","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLoss in 20-F FY2025, filed 2026-02-04"}}},{"predicate":"operating_income","from":{"id":"clm_109041F6F3C0","predicate":"operating_income","value":"128,339,000,000 DKK","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novo Nordisk operating income: 128,339,000,000 DKK\", as of 2024-12-31 (until 2025-12-31). Claim clm_109041F6F3C0, https://asof.is/claim/clm_109041F6F3C0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm.","url":"https://asof.is/claim/clm_109041F6F3C0","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_672756B8F8A9","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-02-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2024, filed 2025-02-05"}},"to":{"id":"clm_672756B8F8A9","predicate":"operating_income","value":"127,658,000,000 DKK","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novo Nordisk operating income: 127,658,000,000 DKK\", as of 2025-12-31. Claim clm_672756B8F8A9, https://asof.is/claim/clm_672756B8F8A9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm.","url":"https://asof.is/claim/clm_672756B8F8A9","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:ProfitLossFromOperatingActivities in 20-F FY2025, filed 2026-02-04"}}},{"predicate":"revenue","from":{"id":"clm_A3B9347CE850","predicate":"revenue","value":"290,403,000,000 DKK","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novo Nordisk revenue: 290,403,000,000 DKK\", as of 2024-12-31 (until 2025-12-31). Claim clm_A3B9347CE850, https://asof.is/claim/clm_A3B9347CE850, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm.","url":"https://asof.is/claim/clm_A3B9347CE850","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8F7EC31D7FFC","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-02-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Revenue in 20-F FY2024, filed 2025-02-05"}},"to":{"id":"clm_8F7EC31D7FFC","predicate":"revenue","value":"309,064,000,000 DKK","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novo Nordisk revenue: 309,064,000,000 DKK\", as of 2025-12-31. Claim clm_8F7EC31D7FFC, https://asof.is/claim/clm_8F7EC31D7FFC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm.","url":"https://asof.is/claim/clm_8F7EC31D7FFC","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Revenue in 20-F FY2025, filed 2026-02-04"}}},{"predicate":"total_assets","from":{"id":"clm_36763BC50C4E","predicate":"total_assets","value":"465,795,000,000 DKK","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novo Nordisk total assets: 465,795,000,000 DKK\", as of 2024-12-31 (until 2025-12-31). Claim clm_36763BC50C4E, https://asof.is/claim/clm_36763BC50C4E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm.","url":"https://asof.is/claim/clm_36763BC50C4E","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BCB17EC648AA","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-02-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2024, filed 2025-02-05"}},"to":{"id":"clm_BCB17EC648AA","predicate":"total_assets","value":"542,902,000,000 DKK","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novo Nordisk total assets: 542,902,000,000 DKK\", as of 2025-12-31. Claim clm_BCB17EC648AA, https://asof.is/claim/clm_BCB17EC648AA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm.","url":"https://asof.is/claim/clm_BCB17EC648AA","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Assets in 20-F FY2025, filed 2026-02-04"}}},{"predicate":"total_equity","from":{"id":"clm_4145313CD790","predicate":"total_equity","value":"143,486,000,000 DKK","valid_from":"2024-12-31","valid_to":"2025-12-31","published":"2025-02-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novo Nordisk total equity: 143,486,000,000 DKK\", as of 2024-12-31 (until 2025-12-31). Claim clm_4145313CD790, https://asof.is/claim/clm_4145313CD790, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm.","url":"https://asof.is/claim/clm_4145313CD790","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_51EBABE50856","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/0001628280-25-003920-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2024","published_at":"2025-02-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2024, filed 2025-02-05"}},"to":{"id":"clm_51EBABE50856","predicate":"total_equity","value":"194,047,000,000 DKK","valid_from":"2025-12-31","valid_to":null,"published":"2026-02-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Novo Nordisk total equity: 194,047,000,000 DKK\", as of 2025-12-31. Claim clm_51EBABE50856, https://asof.is/claim/clm_51EBABE50856, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm.","url":"https://asof.is/claim/clm_51EBABE50856","accessed":"2026-11-10"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/0000353278-26-000012-index.htm","tier":"primary","publisher":"SEC EDGAR 20-F FY2025","published_at":"2026-02-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"ifrs-full:Equity in 20-F FY2025, filed 2026-02-04"}}}],"rule":"Two states compared by claim id: in both, unchanged; only on to, added; only on from, ended. An ended and an added claim on one predicate are a replacement when the ended one points to the added (superseded_by), or the predicate has exactly one of each and the added begins the day the ended ends. Added rows are labelled for to, ended rows for from. Posts and Hugging Face repos are counted in skipped_posts, not listed.","legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}